Headlands Technologies’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-62,400
Closed -$569K 1154
2025
Q2
$569K Buy
62,400
+57,761
+1,245% +$425K 0.07% 279
2025
Q1
$36.9K Buy
+4,639
New +$34K ﹤0.01% 761
2024
Q3
Sell
-3,916
Closed -$42.5K 1484
2024
Q2
$42.5K Buy
3,916
+2,782
+245% +$35.6K ﹤0.01% 798
2024
Q1
$21.3K Buy
+1,134
New +$26.2K 0.01% 896
2023
Q3
Sell
-2,442
Closed -$115K 1164
2023
Q2
$115K Buy
+2,442
New +$121K 0.04% 366

Other funds holding SAGE